We are live on
!
Find out more
OCM
Oakview Capital Management Portfolio holdings
AUM
$21.6M
1-Year Est. Return
20.25%
This Fund
S&P 500
This Quarter
Est. Return
+6.09%
1 Year Est. Return
+20.25%
3 Year Est. Return
+21.24%
5 Year Est. Return
+60.68%
10 Year Est. Return
–
AUM
$280M
AUM Growth
+$29.6M
(+12%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
5.63%
Top 10 Holdings %
Top 10 Hldgs %
78.81%
Holding
17
New
–
Increased
12
Reduced
2
Closed
3
Top Buys
| 1 |
Cardinal Health
CAH
|
+$9.96M |
| 2 |
General Motors
GM
|
+$6.92M |
| 3 |
Enovis
ENOV
|
+$1.13M |
| 4 |
American International
AIG
|
+$1.09M |
| 5 |
ALEX
Alexander & Baldwin
ALEX
|
+$1.02M |
Top Sells
| 1 |
Pfizer
PFE
|
+$5.62M |
| 2 |
CNXM
CNX Midstream Partners LP
CNXM
|
+$3.27M |
| 3 |
GDP
Goodrich Petroleum Corporation Common Stock
GDP
|
+$124K |
| 4 |
VBTX
Veritex Holdings
VBTX
|
+$47K |
| 5 |
Rayonier
RYN
|
+$39K |
Sector Composition
| 1 | Healthcare | 38.99% |
| 2 | Financials | 13.87% |
| 3 | Materials | 10.39% |
| 4 | Communication Services | 9.63% |
| 5 | Consumer Discretionary | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
T-Mobile US
TMUS
$208B
| $26.9M | 9.63% |
383,519
+12,136
| +3% | +$780K |
|
|
2
Pfizer
PFE
$143B
| $26.1M | 9.32% |
623,213
-145,982
| -19% | -$5.62M |
|
|
3
Enovis
ENOV
$1.56B
| $25.2M | 9.03% |
406,602
+19,819
| +5% | +$1.13M |
|
|
4
Cardinal Health
CAH
$53.5B
| $24.8M | 8.86% |
458,624
+194,701
| +74% | +$9.96M |
|
|
5
General Motors
GM
$68.6B
| $23.9M | 8.56% |
710,804
+187,805
| +36% | +$6.92M |
|
|
6
American International
AIG
$42.7B
| $23.3M | 8.34% |
438,143
+20,363
| +5% | +$1.09M |
|
|
CNXM
7
DELISTED
CNX Midstream Partners LP
CNXM
| $19.7M | 7.05% |
1,023,265
-165,127
| -14% | -$3.27M |
|
8
NetApp
NTAP
$32.1B
| $17.4M | 6.23% |
202,945
+2,263
| +1% | +$187K |
|
9
Orthofix Medical
OFIX
$468M
| $16.7M | 5.99% |
289,522
+9,667
| +3% | +$542K |
|
|
COHR
10
DELISTED
Coherent Inc
COHR
| $16.2M | 5.8% |
94,209
+3,599
| +4% | +$633K |
|
11
Chubb
CB
$137B
| $15.4M | 5.52% |
115,562
+7,429
| +7% | +$1M |
|
12
FMC
FMC
$1.4B
| $15M | 5.36% |
198,211
+11,778
| +6% | +$887K |
|
|
ALEX
13
DELISTED
Alexander & Baldwin
ALEX
| $14.8M | 5.28% |
650,147
+42,870
| +7% | +$1.02M |
|
14
DuPont de Nemours
DD
$18.3B
| $14.1M | 5.03% |
86,408
+3,962
| +5% | +$682K |
|
|
15
Rayonier
RYN
$6.56B
| – | – |
-1,124
| Closed | -$39K |
|
|
VBTX
16
DELISTED
Veritex Holdings
VBTX
| – | – |
-1,500
| Closed | -$47K |
|
|
GDP
17
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| – | – |
-10,000
| Closed | -$124K |
|
Similar funds
KLM
SRCM
CMG
TM
A
WA
LC
TOTSC
Oakview Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Oakview Capital Management held 17 positions worth $280M, up 12% from $250M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Oakview Capital Management deployed $15.7M of net new capital in Q3 2018, adding to 12 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 36% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Pfizer, an estimated $5.62M trimmed.
- Oakview Capital Management added most to Cardinal Health in Q3 2018, an estimated $9.96M increase.
- Oakview Capital Management's biggest Q3 2018 reduction was Pfizer, cutting an estimated $5.62M.
- Oakview Capital Management fully exited Goodrich Petroleum Corporation Common Stock in Q3 2018, selling an estimated $124K.
- Oakview Capital Management's ten largest holdings make up 79% of its $280M portfolio in Q3 2018.
- Oakview Capital Management opened 0 new positions and closed 3 in Q3 2018.
- Oakview Capital Management's portfolio value rose 12% quarter-over-quarter to $280M.
Based on Oakview Capital Management's 13F filing for Q3 2018, filed 7 Nov 2018.